Business Wire

IOC Announces New Global Hospitality Model From Paris 2024 Onwards, “On Location” Appointed as Global Hospitality Provider Through to LA28

Share

The International Olympic Committee (IOC) today announced that the IOC, the International Paralympic Committee (IPC), and the Organising Committees of the Olympic Games and Paralympic Games (OCOGs) Paris 2024, Milano Cortina 2026 and LA28 will together introduce a new global hospitality model.

Fans and stakeholders will have access to unique ticket-inclusive travel and hospitality experiences through one, official, exclusive hospitality provider. To support this global hospitality programme, following a multi-stage selection process, On Location, a leader in the experiential hospitality business, has been appointed as the exclusive service provider for the Olympic and Paralympic Games Paris 2024, Milano Cortina 2026 and LA28 hospitality programmes. Working together with the Organising Committees, On Location will deliver world-class hospitality experiences for fans and Olympic stakeholders alike, with packages including tickets, travel, accommodation and unique in-venue and host city hospitality.

The new model will also enhance services for athletes’ families and friends wanting to see their loved ones compete at the Games, with support for travel, access to accommodation, and other services, including dedicated ticket inventory.

IOC President Thomas Bach said: “One of the recommendations of Olympic Agenda 2020+5 is to deliver additional turnkey solutions that could be provided to OCOGs to simplify the delivery complexity of the Games. This new solution will deliver a simplified, secure process for fans around the world to attend the Games. The centralisation of the project also contributes greatly to better oversight and, with this, to good governance. It will also directly support the staging of the Olympic and Paralympic Games, all the National Olympic Committees and most importantly their athletes.”

Tony Estanguet, President of Paris 2024, said: “Paris 2024 will be the first Olympic and Paralympic Games Organising Committee to propose a worldwide hospitality offer. This represents a fantastic opportunity – for us and the entire Paris 2024 ecosystem. Our teams are already at work and we look forward to innovating together, to offer unique hospitality experiences that will appeal to a broad global audience. In developing these new products, we will seek to showcase the best of French ‘art de vivre’, our gastronomy, art, culture, sport and innovation against the magnificent backdrop of the City of Lights, while fully respecting the focus on legacy at the heart of our vision.”

CONI and Milano Cortina 2026 President Giovanni Malagò said: “The new approach to hospitality, adopted by the IOC in line with Olympic Agenda 2020+5, is an important step for the entire Olympic and Paralympic Movement. It will provide a unique experience to our fans and stakeholders around the world, along with an important revenue stream that will help Milano Cortina 2026 to deliver exciting and sustainable Games. This agreement also shows how attractive the Italian Winter Games are at a global level and how great an opportunity they represent for our tourism industry and territories.”

LA28 Chairperson Casey Wasserman said: “On Location brings an incredible track record creating experiences for major global events, and will set a new standard for Olympic and Paralympic Games hospitality. Modernising the hospitality and ticketing platform has been a major priority for us as we prepare to host a world-class event in Los Angeles. This partnership furthers our commitment to deliver an extraordinary Games experience for athletes and fans in our community and around the world.”

On Location President Paul Caine said: “At On Location, we are dedicated to providing our customers with exceptional live event experiences that produce memories to last a lifetime. We are honoured to join the International Olympic Committee in reimagining hospitality at future Olympic and Paralympic Games, and we are committed to providing stakeholders, partners and fans around the globe with exclusive hospitality experiences that uniquely celebrate each host city.”

For a first look at On Location’s approach to hospitality at future Games, visit: www.onlocationexp.com/olympics

The IOC has facilitated this long-term agreement, working in collaboration with the Organising Committees of the Olympic and Paralympic Games Paris 2024, Milano Cortina 2026 and LA28. The Organising Committees and the National Olympic Committees (NOCs) and their Olympic teams will be the primary beneficiaries of the revenue generated through this new centralised approach, which will support the staging of the Olympic and Paralympic Games, the Olympic teams around the world and their athletes.

The reform is part of the Olympic Agenda 2020+5 vision to deliver long-term turnkey solutions that are provided over several editions of the Olympic Games with the aim of simplifying operations and driving efficiency in delivery, as well as driving new revenue sources.

In addition, and separate to the agreement with On Location, a new, integrated approach regarding global ticket sales will also be introduced from Paris 2024 onwards. It will provide secure, seamless access to Olympic and Paralympic tickets directly via each Organising Committee at standardised prices for each Games for fans in all corners of the world.

About the International Olympic Committee
The International Olympic Committee is a not-for-profit, civil, non-governmental, international organisation made up of volunteers which is committed to building a better world through sport. It redistributes more than 90 per cent of its income to the wider sporting movement, which means that every day the equivalent of USD 3.4 million goes to help athletes and sports organisations at all levels around the world.

For more information, please contact the IOC Media Relations Team:
Tel: +41 21 621 6000, email: pressoffice@olympic.org, or visit www.olympics.com

About On Location
On Location is a global leader in premium experiential hospitality, offering ticketing, curated guest experiences, live event production and travel management across sports, entertainment, fashion and culture. On Location provides unrivalled access for corporate clients and fans looking for official, immersive experiences at marquee events, including the Olympic and Paralympic Games, Super Bowl, NCAA Final Four, New York Fashion Week and more. An official partner and/or service provider to over 150 iconic rights holders, such as the IOC (Paris 2024, Milano Cortina 2026, LA28), NFL, NCAA, UFC and PGA of America, and numerous musical artists and festivals, the company also owns and operates a number of its own unique experiences. On Location is a subsidiary of Endeavor (NYSE:EDR), a global entertainment, sports and content company.

Broadcast quality footage
The IOC Newsroom: http://iocnewsroom.com/

Videos
YouTube: www.youtube.com/iocmedia

Photos
For an extensive selection of photos available shortly after each event, please follow us on Flickr.

To request archive photos and footage, please contact our Images team at: images@olympic.org

Social media
For up-to-the-minute information on the IOC and regular updates, please follow us on Twitter, Facebook and YouTube.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

On Location Media Contact:
Kim Ulrich | kulrich@endeavorco.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release

Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release

Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye